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Abstract
Background: We aimed to find support for the hypothesis that telomere length (TL) is causally involved in the pathogenesis
of ischemic heart failure (IHF). We measured TL in IHF patients and their high-risk offspring and determined whether mean
leukocyte TL reflects TL in CD34+ progenitor. We additionally measured TL of offspring of patients and controls to examine
heritability throughout different cell types.
Methods and Results: TL was measured by qPCR in overall leukocytes, CD34+ progenitor cells, mononuclear cells (MNCs),
and buccal cells in 27 IHF patients, 24 healthy controls and 60 offspring. TL in IHF patients was shorter than healthy controls
in leukocytes (p = 0.002), but not in CD34+ cells (p = 0.39), MNCs (p = 0.31) or buccal cells (p = 0.19). Offspring of IHF patients
had shorter TL in leukocytes than offspring of healthy subjects (p = 0.04) but not in other cell types. Controls and offspring
showed a good within person correlation between leukocytes and CD34+ cells (r 0.562; p = 0.004 and r 0.602; p = 0.001,
respectively). In IHF patients and offspring the correlation among cell types was blunted. Finally, we found strong
correlations between parent and offspring TL in all four cell types.
Conclusions: Reduced leukocyte TL in offspring of IHF subjects suggests a potential causal link of TL in ischemic heart
disease. However, this causality is unlikely to originate from exhaustion of TL in CD34+ progenitor or MNC cells as their
lengths are not well captured by overall leukocyte TL. Additionally, we found strong correlations between parent and
offspring TL in all examined cell types, suggesting high heritability of TL among cell types.
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Introduction
Telomeres are the terminal ends of the DNA strands, and
shorten during life because of incomplete DNA replication after
cell cycling or damaging environmental factors. Cells with
critically short telomeres become dysfunctional, and can even-
tually even go into apoptosis [1,2]. Recently, telomere biology
has been implicated in aging associated cardiovascular diseases.
Most data has been generated on establishing the association
between short mean overall leukocyte telomere length (TL) and
ischemic heart disease (IHD) [3,4,5,6]. In addition, it has been
suggested that presumably healthy offspring of patients with
ischemic heart disease already have shorter TL compared to
healthy offspring of controls [7]. An open question remains
whether telomere length is causally involved in the development
of heart disease, and if so, what the underlying mechanism is.
Short overall mean leukocyte telomere length has been viewed as
a reflection of short telomere length in other cells, possibly of
vascular progenitor cells, and thereby providing a link to an
impaired vascular repair mechanism potentially causing ischemic
heart disease.
To further dissect the association of ischemic heart disease with
mean overall leukocyte TL we need to establish whether mean
overall leukocyte TL is a reflection of TL in different cell types or
whether it is more or less specific for leukocytes. Of particular
interest in this regard are the CD34 positive (CD34+) cells as it is
thought that these cells might be cardiovascular progenitor cells
and play a role in cardiovascular repair [8,9,10]. Short TL in
CD34+ cells might provide a mechanism for the association with
IHD as their cellular dysfunction might impair cardiovascular
repair. Furthermore, mean leukocyte telomere length has not been
compared to non-circulating non-vascular cells and it is unknown
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whether leukocytes might merely be a reflection of overall TL of
the whole body [11].
We have investigated telomere length in circulating leukocytes,
CD34+ cells, mononuclear cells, and the non-systemic non-
circulating buccal cells in patients with ischemic heart failure (IHF)
– which is the most extreme phenotype of IHD – and compared
them to healthy, age-matched controls. Since occurrence of IHD is
highly familial and telomere length is an inheritable trait
[12,13,14], we also aimed to determine whether telomere length
in the different cell types is shorter in offspring of IHF patients
compared to offspring of healthy controls.
Methods
Ethics statement
The study was approved by the local Medical Ethical
Committee for human research of the University Medical Center
Groningen (UMCG) and adheres to the Declaration of Helsinki.
All participants were aged 18 or older and provided written
informed consent for participation in this study.
Study design
The Telosophy study is an observational, prospective case-
control study. Groups consisted of 1) patients with stable
ischemic heart failure (IHF) and 2) age and gender matched
healthy controls. In addition, of both groups we included off-
spring; (3) offspring of IHF patients, and (4) offspring of healthy
controls.
The inclusion criteria for the IHF patients were: presence of
coronary artery disease (previous myocardial infarction and/or
coronary revascularisation), left ventricular ejection fraction
(LVEF) #40%, having heart failure for at least 6 months and
being stable on optimal medication for heart failure for at least 4
weeks prior to the study visit, and having at least one healthy
biological child that was willing to participate. Exclusion criteria
were having had an ischemic cardiac event in the past 12 months
and having severe cardiac valvular disease. Inclusion criteria for
controls were being age- and gender- matched to the IHF patients,
and having at least one healthy biological child who was willing to
participate. Exclusion criteria for healthy controls were having
known atherosclerotic disease or heart failure, a family history of
premature cardiovascular disease, and having a partner (who is the
biological parent of the participating offspring) with known
cardiovascular disease. In addition, main exclusion criteria for
all participants were having systemic inflammatory diseases,
haematopoietic diseases, severe renal of liver disease, uncontrolled
hypothyroidism, premature aging syndromes, or malignancies,
which could all influence telomere length.
Study visit
IHF patients were recruited from the outpatient clinic of the
Universitair Medical Center Groningen in Groningen, the
Netherlands. Healthy controls were recruited with local advertise-
ments or screened at the pre-operative outpatient clinic for
planned selective non-cardiovascular surgery (small plastic surgery,
ophtalmic surgery or minor orthopaedic procedures).
Subjects underwent 1 study visit to assess medical and family
history and life style factors and to undergo a physical exam.
Venous blood samples (60 mL in collected in tubes precoated
with EDTA and 2.5 mL in the PAXgene Blood RNA tube,
catalogno. 762174, Qiagen, Venlo, The Netherlands) and a
buccal mucosa cells (four buccal swabs (isohelix, SK-4)) samples
were taken.
Isolation of CD34+ cells
Peripheral blood mononuclear cells were obtained from venous
whole blood after density gradient centrifugation (Ficoll Paque
Plus, catalogno. 17-1440-02, GE Healthcare Europe GmbH,
Diegem, Belgium). The mononuclear cell (MNC) fraction was
incubated with magnetic beads conjugated to anti-CD34-antibody
(CD34 Microbead Kit, catalogno. 130-046-702, Miltenyi Biotec,
Bergisch Gladbach, Germany). Subsequently, CD34+ cells were
obtained from the MNC fraction by magnetic bead cell selection
(MidiMACS separator, Miltenyi Biotec, Bergisch Gladbach,
Germany). Flow cytometric analysis of mononuclear cells showed
that incubation with anti-CD34-antibody and magnetic beads
increased the CD34+ cell isolation from 0.39% to 58.81% (data
not shown).
Telomere length measurement
DNA isolation of CD34+ cells, MNCs, and buccal swabs was
performed according to manufacturer’s protocol (NucleoSpin
Tissue kit, catalogno. 740952, Macherey-Nagel/Bioke´, Leiden,
The Netherlands). Relative telomere length (TL) was assessed by
monochrome multiplex quantitative PCR method, previously
described in detail [15,16], and expressed as the ratio of telomere
(T) to reference copies (S), further called T/S ratio. Samples of
IHF patients, controls, and both offspring groups were randomly
assigned to the plates and plate positions, with each plate
containing samples of all four groups. All samples were run in
triplicate. Samples with a coefficient of variation larger than 0.10
were run again. No samples had a coefficient of variation larger
than 0.10 after the second run.
Data were characterised as outliers when .4 times standard
deviation and were excluded from all statistical analyses (N= 1).
Statistical analysis
Skewed variables were natural log transformed to acquire
normal distribution. Differences in means between the groups
were tested with Student’s T-test or Chi square test. Pearson (or
Spearman) and linear regression techniques were used to asses
associations between variables of interest. Multivariate linear
regression analysis was used to make adjustments. All statistical
analyses were performed in SPSS version 16.0 (SPSS inc. Chicago,
Illinois). A two-sided p-value of #0.05 was interpreted to indicate
statistical significance.
Results
Baseline characteristics
Baseline characteristics per group are presented in Table 1. All
IHF patients had experienced previous myocardial infarction. On
average, IHF patients were aged 69 years, had a mean LVEF of
27%, 85% was male, and were well treated.
Offspring of IHF patients had a higher BMI and tended to have
more frequently hypercholesterolemia compared to offspring of
controls.
Telomere length in leukocyte subpopulations in patients,
controls, and their offspring
In concordance with previous findings [17,18], we observed
shorter leukocyte TL in IHF patients compared to controls
(Figure 1). We also observed shorter leukocyte TL in offspring of
IHF patients compared to offspring of healthy controls (Figure 1).
One of the aims of this study was determining whether telomere
length of CD34+ cells is different in IHF patients compared to
healthy controls. We did not find a difference in TL between IHF
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patients and controls in CD34+ cells (mean TL 6 standard
deviation 0.5660.17 and 0.6060.14, respectively, p = 0.39). Also
the TL of MNCs was similar (0.4660.12 and 0.4960.10,
respectively, p = 0.31) as were TL of buccal cells (0.9760.27 and
1.0460.19, respectively, p = 0.19). In offspring, TL observed in
CD34+ cells (0.6660.16 and 0.7160.16; p = 0.22), MNCs
(0.6260.17 and 0.6260.17; p = 0.96), and buccal cells (1.176
0.42 and 1.2160.25; p = 0.47) were comparable.
These results clearly indicate that there is no significant
difference in CD34+ cell TL between IHF patients and controls.
CD34+ cell dysfunction as a result of short TL is therefore an
improbable player in the pathogenesis of IHF.
Strong correlation between leukocyte and CD34+ in
controls and their offspring, but not IHF patients and
their offspring
Another aim of this study was to investigate whether within one
individual the more frequently reported leukocyte TL mirrors TL
of the cells of our interest, the CD34+ cells. Therefore, we
examined the correlation between TL of leukocytes and CD34+
cells. Interestingly, we found strong correlations between TL of
leukocytes and CD34+ cells in controls and their offspring but not
in IHF patients or their offspring (Table 2)
Strong correlations between parent and offspring TL in
all cell types
We found a positive association of TL between parent and
offspring in leukocytes (correlation coefficient r 0.440, p = 0.002).
We also observed this association in CD34+ cells (r 0.401,
p = 0.004), MNCs (r 0.526, p,0.001), ), and in buccal cells (r
0.391, p = 0.005) (Figure 2). These associations remained signif-
icant after correction for age of parent and offspring (for leukocytes
r 0.448, p = 0.004), for MNCs r 0.547, p,0.001; for CD34+ cells r
0.397, p = 0.004; for buccal cells r 0.368, p = 0.010). We could not
validate earlier findings suggesting an association of paternal age at
time of birth with offspring telomere length [13].
Table 1. Baseline characteristics.
Patient characteristics
I: CHF patients
N=27
II: Healthy
controls
N=24 P-value
III: Offspring
of CHF patients
N=29
IV: Offspring of
healthy controls
N=25 P-value
Age (years) 6966.9 6666.6 0.14 4066.8 3866.0 0.28
Male (n (%)) 23 (85) 20 (83) 0.86 17 (59) 9 (36) 0.10
Age of onset CHF (years) 6068.5 - - - - -
Body mass index (kg/m2) 28.065.0 25.363.0 0.04 27.264.5 24.062.4 0.002
Left ventricular ejection fraction (%) 2768.2 - - - -
NYHA class (n (%)) - -
II 12 - - -
III 15 - - -
IV 0 - - -
CRP (mg/L) 0.0 [0.0–0.0] 0.0 [0.0–0.0] 0.38 0.060.0 0.060.0 0.55
NTproBNP (pg/mL) 665 [364–1524] 52 [35–63] ,0.001 24 [11–41] 19 [8–45] 0.97
Heart rate (beats/min) 6668 6769 0.76 69613 71610 0.47
Blood pressure (mmHg)
Systolic 114615 133618 ,0.001 123618 121617 0.64
Diastolic 68610 80611 ,0.001 76611 77613 0.71
Medical history (n (%))
Myocardial infarction 27 (100) 0 (0) ,0.001 0 (0) 0 (0) 1.00
Hypertension 4 (15) 5 (21) 0.57 2 (7) 1 (4) 0.64
Diabetes mellitus 8 (30) 1 (4) 0.02 1 (3) 0 (0) 0.35
Atrial fibrillation/flutter 11 (37) 0 (0) ,0.001 1 (3) 0 (0) 0.35
Stroke 3 (11) 0 (0) 0.09 0 (0) 0 (0) 1.00
Hypercholesterolaemia 13 (48) 0 (0) ,0.001 4 (14) 0 (0) 0.05
Medication
Beta-blocker 26 (96) 3 (13) ,0.001 1 (3) 0 (0) 0.35
ACE inhibitor and/or AII antagonist 27 (100) 3 (13) ,0.001 1 (3) 1 (4) 0.92
Aldosterone antagonist 7 (26) 0 (0) 0.007 0 (0) 0 (0) 1.00
Diuretic 22 (81) 1 (4) ,0.001 2 (7) 1 (4) 0.64
Statin 24 (89) 1 (4) ,0.001 3 (10) 0 (0) 0.10
Anticoagulant 26 (96) 0 (0) ,0.001 0 (0) 0 (0) 1.00
Data is presented as mean 6 standard deviation or number (%). CHF – chronic heart failure; MNC – mononuclear cells; CD34+ – CD34-positive cells; The body-mass
index is the weight in kilograms divided by the square of the height in meters; NYHA – New York Heart Association functional class; CRP – C-reactive protein; NTproBNP
– N-terminal proB-type Natriuretic Peptide; ACE – Angiotensin Converting Enzyme; AII – Angiotensin II.
doi:10.1371/journal.pone.0023118.t001
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Discussion
Shorter mean leukocyte TL is a remarkable and consistent
finding in subjects with ischemic heart disease, but the reason is
not known. Nevertheless, short overall mean leukocyte telomere
length has been viewed as a reflection of short telomere length in
other cells, possibly of vascular progenitor cells, and thereby
providing a link to an impaired vascular repair mechanism
potentially causing ischemic heart disease. We indeed observed a
good correlation between overall mean leukocyte telomere length
and CD34+, MNCs and buccal cells in healthy subjects and also in
their offspring. However, these high intra-individual correlations
were lost in subjects with IHF and their offspring. The major
difference in telomere length between IHF patients and controls
was observed in the overall leukocyte pool, not specifically in
CD34+, MNCs or buccal cells as a source of non-blood derived
cells. We confirmed earlier findings, suggesting shorter leukocyte
telomere length in offspring of patients with coronary artery
disease versus offspring of healthy controls [7]. Finally, we
confirmed the strong associations between parent and offspring
TL in all four cell types we examined.
The comparable TL of CD34+ cells in cases and controls and
both offspring groups are consistent with earlier findings [19] and
strongly suggest that telomere shortening of CD34+ cells is not a
major player in the pathophysiology of IHD. If there is any role of
TL in this process – the consistent finding of shorter leukocyte TL
in IHD patients does support this allegation – it would rather
involve other leukocyte populations. It is known that leukocyte
function changes with aging. In the elderly, specific immune
responses might be diminished, but many other functions are
unchanged or even augmented compared to young persons [20].
A state of low-grade chronic inflammation has been recognized in
elderly, which makes them prone to chronic inflammatory
diseases, including atherosclerosis [20]. Macrophages, and to a
lesser extent other leukocytes, catalyse the process of atheroscle-
rosis by eliciting an enhanced systemic inflammatory response,
possibly through increased oxidative stress [20,21,22]. Interest-
ingly, it has been demonstrated that macrophages with short
telomeres are more susceptible to damage from oxidative stress,
and in addition have higher intracellular concentrations of
oxidative stress molecules [23], which are suggested to be a
driving force in the development and progression of atherosclerosis
[21]. These data strongly suggest that aging – chronologically or
biologically – of leukocytes can possibly augment their unbeneficial
contribution to IHD.
A secondary focus of our study was the heredity of TL traits
among cell populations. Heritability of mean leukocyte telomere
length has been demonstrated previously [12,14,24]. We now add
to this the heritability patterns in TL derived from different cell
fractions. A tissue specific TL regulation has been suggested, since
TLs differ between different types of tissue [11]. In addition,
external influences on TL are acknowledged. For instance, it has
been shown that vascular endothelial cells that endure more
hemodynamic sheer stress have shorter telomeres than endothelial
cells in low pressure arteries [25]. Also, oxidative stress is a well-
known factor that causes telomere shortening [26]. Our results
indicate that despite external influences and tissue specific TL
regulation, TL is a highly inheritable trait throughout different cell
types.
Figure 1. Mean leukocyte telomere length of all groups.
doi:10.1371/journal.pone.0023118.g001
Table 2. Correlation coefficients between Cd34+ cells and
other cell types within patients, controls, and offspring.
Correlation coefficient r P value
CHF patients 0.313 0.137
Healthy controls 0.562 0.004
Offspring of CHF patients 0.210 0.324
Offspring of healthy controls 0.602 0.001
doi:10.1371/journal.pone.0023118.t002
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Strengths and limitations
Our study is strengthened by the fact that we not only
examined TL of IHF patients and controls, but also of their
offspring. Our finding that TL in healthy offspring of IHF
patients is shorter than in healthy offspring of controls supports
the hypothesis that, next to the genetic predisposition to coronary
artery disease deriving from specific genes, TL might also be a
factor contributing to familial predisposition to IHD. Further-
more, we separated leukocyte cell fractions to determine
differential expression of TL. This is significant, since knowledge
on which specific cell types contribute to the shorter mean
leukocyte TL is necessary in order to identify a potential
mechanism underlying the association between TL and IHD.
To our knowledge, our study is the first study that investigated
both heritability features and differential expression of TL in
leukocyte subpopulations. Also, our study was a prospective
study, meaning all measures were taken in advance to preserve
blood and tissue samples taken from participants, which
contributed to high accuracy of experimental procedures and
laboratory measurements.
We also have to acknowledge some limitations. The separation
of white blood cells was limited to MNCs and CD34+. Because of
potential functional relevance, our main interest was the CD34+
cell population. However, we demonstrated that the CD34+ cell
population is not the cell population that drives the difference in
leukocyte TL between IHF patients and controls. This difference
must thus lie in other leukocyte cell populations that we did not
separately analyse in this study.
Figure 2. Correlations between parent and offspring telomere length in leukocytes (A), CD34+ cells (B), mononuclear cells (C), and
buccal cells (D).
doi:10.1371/journal.pone.0023118.g002
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Conclusions
In conclusion, we found that TL is shorter in leukocytes of IHF
patients and their healthy offspring compared to healthy controls
and their healthy offspring. This is supporting evidence for a
causal role of TL in familial predisposition to ischemic heart
disease. The fact that we did not find a difference in TL of CD34+
cells between IHF patients and healthy controls, suggests that these
cells are not involved in the potential mechanism linking short TL
and ischemic heart disease. Furthermore, we found good
correlations between parent and offspring TL in all cell types we
examined, indicating a strong inheritance pattern of TL. Evidence
for a causal role of TL in ischemic heart disease will be helpful in
finding new therapeutic targets.
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